Literature DB >> 8949388

[Mechanisms of reduction of CD4 receptor expression on the surface of HIV-1 infected cells].

R Geleziunas1, N Morin, M A Wainberg.   

Abstract

Specific interactions between the cell surface CD4 receptor and the HIV-1 envelope glycoprotein gp120 are responsible for the entry of HIV into host cells. Following infection, a down-modulation of CD4 at the cell surface is commonly observed. This may render cells resistant to subsequent infection by HIV as well as other viruses that also use CD4 as a portal of entry. This phenomenon is termed retroviral interference. CD4 down-modulation is complex and involves at least 3 viral gene products which include the envelope precursor gp160 and 2 auxilliary proteins Nef and Vpu. CD4 down-modulation has been observed in each of primary CD4+ T-lymphocytes and monocyte-derived macrophages, as well as both T and monocytic cell lines. CD4 down-regulation may occur at different levels. Specific binding of soluble gp120 may lead to internalization of CD4. The HIV-1 nef gene product which is expressed prior to HIV-1 structural proteins also causes the internalization of CD4 followed by its lysosomal degradation. During the late phase of viral gene expression i.e. viral structural protein synthesis, CD4-gp160 complexes forming in the ER represent another important factor leading to CD4 down-modulation. Finally, CD4 which is retained by gp160 in the ER, is specifically degraded in the presence of Vpu. Thus, it appears that CD4 down-regulation is of central importance to the life cycle of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949388

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  4 in total

1.  Human retinal microglia express candidate receptors for HIV-1 infection.

Authors:  V T Pham; L Wen; P McCluskey; M C Madigan; P L Penfold
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells.

Authors:  E Hermann; E Darcissac; T Idziorek; A Capron; G M Bahr
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

3.  Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells.

Authors:  M J Truong; E C Darcissac; E Hermann; J Dewulf; A Capron; G M Bahr
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  A novel HIV-1 reporter virus with a membrane-bound Gaussia princeps luciferase.

Authors:  Nuttee Suree; Naoya Koizumi; Anna Sahakyan; Saki Shimizu; Dong Sung An
Journal:  J Virol Methods       Date:  2012-03-31       Impact factor: 2.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.